-
-
In this issue: The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
-
-
The final report on the three-year recovery audit contractor (RAC) demonstration project for hospitals shows that the Centers for Medicare & Medicaid Services (CMS) has made "a lot of important changes," says Don May, vice president of policy for the American Hospital Association (AHA).
-
The largest patient "look-back" notification in medical history involving some 40,000 patients potentially exposed to hepatitis C, HBV, and HIV in a Las Vegas endoscopy clinic allegedly was driven by policies designed to save money and carried out by medical staff who should have known they were putting patients at risk, Hospital Infection Control has learned.
-
-
-
Dual antiplatelet therapy (DAPT) following coronary stenting is essential for the prevention of stent thrombosis, which can occur due to a response to the vascular scaffold, as well as to the local inflammation that occurs after angioplasty. DAPT after drug-eluting stent (DES) implantation is currently recommended for at least 12 months in the United States and for 6 months in Europe.
-
Symptomatic left ventricular outflow tract (LVOT) obstruction is common in patients with hypertrophic obstructive cardiomyopathy (HOCM), and medical therapy does not always relieve the symptoms. In such cases, septal reduction therapies are indicated, and both alcohol septal ablation (ASA) and surgical myectomy have been proven to reduce symptoms effectively.
-
Although carotid artery stenting (CAS) is a less invasive means of carotid revascularization, multiple trials have demonstrated an increased risk of post-procedural stroke in patients with symptomatic carotid stenosis, as compared to carotid endarterectomy (CEA).
